Virtu Financial’s Kindred Biosciences, Inc. KIN Stock Holding History

Virtu Financial’s Portfolio KIN Stock Details KIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-22,991	Closed	-$211K	–	2325
2021 Q2	$211K	Buy	+22,991	New	+$134K	0.02%	963
2021 Q1	–	Sell	-29,908	Closed	-$129K	–	2301
2020 Q4	$129K	Buy	+29,908	New	+$122K	0.01%	992

Other funds holding KIN

CFO

CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return

Virtu Financial's KIN Position: Q3 2021 in Review

Virtu Financial sold out of Kindred Biosciences, Inc. (KIN) in Q3 2021, closing a stake of 22,991 shares — an estimated $211K sold.

Virtu Financial first reported a position in KIN in Q4 2020 and held it in 2 quarters. The position peaked at $211K in Q2 2021. 1 fund tracked by Wall St. Rank holds KIN as of Q3 2021.

Virtu Financial reported no remaining Kindred Biosciences, Inc. position as of Q3 2021 after selling out during the quarter.
Virtu Financial sold 22,991 Kindred Biosciences, Inc. shares in Q3 2021, an estimated $211K.
Virtu Financial first reported a position in Kindred Biosciences, Inc. in Q4 2020 and held it in 2 quarters.
Virtu Financial's Kindred Biosciences, Inc. position peaked at $211K in Q2 2021.
1 fund tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q3 2021.

Based on Virtu Financial's 13F filing for Q3 2021, filed 12 Nov 2021.